COPENHAGEN, Denmark, Aug. 23, 2012 (GLOBE NEWSWIRE) -- Zealand Pharma A/S (Copenhagen:ZEAL), a biotech company dedicated to the discovery and development of peptide drugs, reports revenue growth, a net profit and an increase in cash and securities combined with the achievement of several important pipeline milestones for the six month period 1 January to 30 June 2012.
